We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$73.9B
AUM Growth
-$2.32B
Cap. Flow
-$2.03B
Cap. Flow %
-2.75%
Top 10 Hldgs %
22.54%
Holding
3,088
New
93
Increased
1,359
Reduced
1,564
Closed
46

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$60.7M
2
ADI icon
Analog Devices
ADI
+$46.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37.3M
4
MTCH icon
Match Group
MTCH
+$28.2M
5
GXO icon
GXO Logistics
GXO
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 23.91%
2 Financials 14.2%
3 Healthcare 13.07%
4 Consumer Discretionary 12.09%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
26
Intel
INTC
$455B
$376M 0.51%
7,059,194
-195,433
-3% -$10.6M
VZ icon
27
Verizon
VZ
$195B
$370M 0.5%
6,843,632
-547,030
-7% -$30.3M
PFE icon
28
Pfizer
PFE
$143B
$369M 0.5%
8,572,831
+188,970
+2% +$8.37M
ABT icon
29
Abbott
ABT
$183B
$366M 0.49%
3,094,463
-14,742
-0.5% -$1.81M
COST icon
30
Costco
COST
$422B
$350M 0.47%
778,519
-17,385
-2% -$7.64M
PEP icon
31
PepsiCo
PEP
$190B
$343M 0.46%
2,277,986
-56,603
-2% -$8.76M
TMO icon
32
Thermo Fisher Scientific
TMO
$213B
$340M 0.46%
595,469
-13,422
-2% -$7.37M
KO icon
33
Coca-Cola
KO
$377B
$335M 0.45%
6,375,509
-196,692
-3% -$11M
WMT icon
34
Walmart Inc
WMT
$885B
$329M 0.45%
7,079,082
-169,215
-2% -$8.15M
ACN icon
35
Accenture
ACN
$102B
$328M 0.44%
1,024,558
-30,693
-3% -$9.98M
T icon
36
AT&T
T
$159B
$322M 0.44%
15,772,390
-1,423,911
-8% -$29.9M
CVX icon
37
Chevron
CVX
$392B
$314M 0.42%
3,091,637
-105,689
-3% -$10.5M
AVGO icon
38
Broadcom
AVGO
$1.85T
$312M 0.42%
6,436,590
-114,010
-2% -$5.54M
TXN icon
39
Texas Instruments
TXN
$252B
$312M 0.42%
1,621,598
-37,381
-2% -$7.12M
MCD icon
40
McDonald's
MCD
$192B
$311M 0.42%
1,290,470
-19,484
-1% -$4.65M
WFC icon
41
Wells Fargo
WFC
$261B
$308M 0.42%
6,626,498
-217,307
-3% -$10.1M
LLY icon
42
Eli Lilly
LLY
$1.02T
$302M 0.41%
1,309,105
-37,477
-3% -$9.25M
DHR icon
43
Danaher
DHR
$137B
$300M 0.41%
1,112,455
-32,527
-3% -$8.85M
NKE icon
44
Nike
NKE
$61.9B
$297M 0.4%
2,048,353
-56,775
-3% -$9.26M
ABBV icon
45
AbbVie
ABBV
$443B
$284M 0.38%
2,630,160
-51,334
-2% -$5.87M
MRK icon
46
Merck
MRK
$322B
$277M 0.37%
3,681,268
-204,150
-5% -$15.5M
MDT icon
47
Medtronic
MDT
$109B
$265M 0.36%
2,116,790
-50,125
-2% -$6.49M
NEE icon
48
NextEra Energy
NEE
$181B
$264M 0.36%
3,362,202
-136,417
-4% -$11M
ORCL icon
49
Oracle
ORCL
$374B
$256M 0.35%
2,941,796
-448,143
-13% -$39.6M
LOW icon
50
Lowe's Companies
LOW
$117B
$253M 0.34%
1,247,373
+3,276
+0.3% +$653K

Similar funds

RhumbLine Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 93 new positions and exited 46, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
  • RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
  • RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
  • RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
  • RhumbLine Advisers opened 93 new positions and closed 46 in Q3 2021.
  • RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.

Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.